|
The exceptional stability of the CCK framework of cyclotides
makes it an attractive framwork in drug design applications. A
company, Kalthera Pty Ltd, has been established to pursue
commercial applications of cyclotides.
Contact details:
Professor D J Craik
Managing Director
Kalthera Pty Ltd
Level 7
Gehrmann Laboratories
University of Queensland
Brisbane 4072
Australia
|